Fractional laser-assisted drug delivery: Active filling of laser channels with pressure and vacuum alteration

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Fractional laser-assisted drug delivery : Active filling of laser channels with pressure and vacuum alteration. / Erlendsson, Andrés M; Doukas, Apostolos G; Farinelli, William A; Bhayana, Brijesh; Anderson, R Rox; Haedersdal, Merete.

I: Lasers in Surgery and Medicine, Bind 48, Nr. 2, 02.2016, s. 116-24.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Erlendsson, AM, Doukas, AG, Farinelli, WA, Bhayana, B, Anderson, RR & Haedersdal, M 2016, 'Fractional laser-assisted drug delivery: Active filling of laser channels with pressure and vacuum alteration', Lasers in Surgery and Medicine, bind 48, nr. 2, s. 116-24. https://doi.org/10.1002/lsm.22374

APA

Erlendsson, A. M., Doukas, A. G., Farinelli, W. A., Bhayana, B., Anderson, R. R., & Haedersdal, M. (2016). Fractional laser-assisted drug delivery: Active filling of laser channels with pressure and vacuum alteration. Lasers in Surgery and Medicine, 48(2), 116-24. https://doi.org/10.1002/lsm.22374

Vancouver

Erlendsson AM, Doukas AG, Farinelli WA, Bhayana B, Anderson RR, Haedersdal M. Fractional laser-assisted drug delivery: Active filling of laser channels with pressure and vacuum alteration. Lasers in Surgery and Medicine. 2016 feb.;48(2):116-24. https://doi.org/10.1002/lsm.22374

Author

Erlendsson, Andrés M ; Doukas, Apostolos G ; Farinelli, William A ; Bhayana, Brijesh ; Anderson, R Rox ; Haedersdal, Merete. / Fractional laser-assisted drug delivery : Active filling of laser channels with pressure and vacuum alteration. I: Lasers in Surgery and Medicine. 2016 ; Bind 48, Nr. 2. s. 116-24.

Bibtex

@article{6d3344e8c53e453aad0dd8dcd3289b90,
title = "Fractional laser-assisted drug delivery: Active filling of laser channels with pressure and vacuum alteration",
abstract = "BACKGROUND AND OBJECTIVE: Ablative fractional laser (AFXL) is rapidly evolving as one of the foremost techniques for cutaneous drug delivery. While AFXL has effectively improved topical drug-induced clearance rates of actinic keratosis, treatment of basal cell carcinomas (BCCs) has been challenging, potentially due to insufficient drug uptake in deeper skin layers. This study sought to investigate a standardized method to actively fill laser-generated channels by altering pressure, vacuum, and pressure (PVP), enquiring its effect on (i) relative filling of individual laser channels; (ii) cutaneous deposition and delivery kinetics; (iii) biodistribution and diffusion pattern, estimated by mathematical simulation.METHODS: Franz diffusion chambers (FCs) were used to evaluate the PVP-technique, comparing passive (AFXL) and active (AFXL + PVP) channel filling. A fractional CO2-laser generated superficial (225 µm;17.5 mJ/channel) and deep (1200 µm; 130.5 mJ/channel) channels, and PVP was delivered as a 3-minutes cycle of 1 minute pressure (+1.0 atm), 1 minute vacuum (-1.0 atm), and 1 minute pressure (+1.0 atm). Filling of laser channels was visualized with a colored biomarker liquid (n = 12 FCs, n = 588 channels). Nuclear magnetic resonance quantified intracutaneous deposition of topically applied polyethylene glycol (PEG400) over time (10 minutes, 1 hour, and 4 hours), investigated with (n = 36 FCs) and without (n = 30 FCs) PVP-filling. Two-dimensional mathematical simulation was used to simulate intradermal biodistribution and diffusion at a depth of 1,000 µm.RESULTS: Active filling with application of PVP increased the number of filled laser channels. At a depth of 1,000 µm, filling increased from 44% (AFXL) to 94% with one PVP cycle (AFXL + PVP; P < 0.01). Active filling greatly enhanced intracutaneous deposition of PEG400, resulting in a rapid delivery six-folding uptake at 10 minutes (AFXL 54 µg/ml vs. AFXL + PVP 303 µg/ml, P < 0.01). AFXL alone generated an inhomogeneous uptake of PEG400, which greatly improved with active filling, resulting in a uniform uptake within the entire tissue.CONCLUSION: Active filling with PVP secures filling of laser channels and induces a deeper, greater, more rapid delivery than conventional AFXL. This delivery technique has promise to improve treatment efficacy for medical treatments of dermally invasive lesions, such as BCCs.",
keywords = "Administration, Cutaneous, Animals, Biomechanical Phenomena, Diffusion, Drug Delivery Systems, Female, Kinetics, Lasers, Gas, Polyethylene Glycols, Pressure, Skin, Swine, Vacuum, Journal Article",
author = "Erlendsson, {Andr{\'e}s M} and Doukas, {Apostolos G} and Farinelli, {William A} and Brijesh Bhayana and Anderson, {R Rox} and Merete Haedersdal",
note = "{\textcopyright} 2015 Wiley Periodicals, Inc.",
year = "2016",
month = feb,
doi = "10.1002/lsm.22374",
language = "English",
volume = "48",
pages = "116--24",
journal = "Lasers in Surgery and Medicine",
issn = "0196-8092",
publisher = "JohnWiley & Sons, Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - Fractional laser-assisted drug delivery

T2 - Active filling of laser channels with pressure and vacuum alteration

AU - Erlendsson, Andrés M

AU - Doukas, Apostolos G

AU - Farinelli, William A

AU - Bhayana, Brijesh

AU - Anderson, R Rox

AU - Haedersdal, Merete

N1 - © 2015 Wiley Periodicals, Inc.

PY - 2016/2

Y1 - 2016/2

N2 - BACKGROUND AND OBJECTIVE: Ablative fractional laser (AFXL) is rapidly evolving as one of the foremost techniques for cutaneous drug delivery. While AFXL has effectively improved topical drug-induced clearance rates of actinic keratosis, treatment of basal cell carcinomas (BCCs) has been challenging, potentially due to insufficient drug uptake in deeper skin layers. This study sought to investigate a standardized method to actively fill laser-generated channels by altering pressure, vacuum, and pressure (PVP), enquiring its effect on (i) relative filling of individual laser channels; (ii) cutaneous deposition and delivery kinetics; (iii) biodistribution and diffusion pattern, estimated by mathematical simulation.METHODS: Franz diffusion chambers (FCs) were used to evaluate the PVP-technique, comparing passive (AFXL) and active (AFXL + PVP) channel filling. A fractional CO2-laser generated superficial (225 µm;17.5 mJ/channel) and deep (1200 µm; 130.5 mJ/channel) channels, and PVP was delivered as a 3-minutes cycle of 1 minute pressure (+1.0 atm), 1 minute vacuum (-1.0 atm), and 1 minute pressure (+1.0 atm). Filling of laser channels was visualized with a colored biomarker liquid (n = 12 FCs, n = 588 channels). Nuclear magnetic resonance quantified intracutaneous deposition of topically applied polyethylene glycol (PEG400) over time (10 minutes, 1 hour, and 4 hours), investigated with (n = 36 FCs) and without (n = 30 FCs) PVP-filling. Two-dimensional mathematical simulation was used to simulate intradermal biodistribution and diffusion at a depth of 1,000 µm.RESULTS: Active filling with application of PVP increased the number of filled laser channels. At a depth of 1,000 µm, filling increased from 44% (AFXL) to 94% with one PVP cycle (AFXL + PVP; P < 0.01). Active filling greatly enhanced intracutaneous deposition of PEG400, resulting in a rapid delivery six-folding uptake at 10 minutes (AFXL 54 µg/ml vs. AFXL + PVP 303 µg/ml, P < 0.01). AFXL alone generated an inhomogeneous uptake of PEG400, which greatly improved with active filling, resulting in a uniform uptake within the entire tissue.CONCLUSION: Active filling with PVP secures filling of laser channels and induces a deeper, greater, more rapid delivery than conventional AFXL. This delivery technique has promise to improve treatment efficacy for medical treatments of dermally invasive lesions, such as BCCs.

AB - BACKGROUND AND OBJECTIVE: Ablative fractional laser (AFXL) is rapidly evolving as one of the foremost techniques for cutaneous drug delivery. While AFXL has effectively improved topical drug-induced clearance rates of actinic keratosis, treatment of basal cell carcinomas (BCCs) has been challenging, potentially due to insufficient drug uptake in deeper skin layers. This study sought to investigate a standardized method to actively fill laser-generated channels by altering pressure, vacuum, and pressure (PVP), enquiring its effect on (i) relative filling of individual laser channels; (ii) cutaneous deposition and delivery kinetics; (iii) biodistribution and diffusion pattern, estimated by mathematical simulation.METHODS: Franz diffusion chambers (FCs) were used to evaluate the PVP-technique, comparing passive (AFXL) and active (AFXL + PVP) channel filling. A fractional CO2-laser generated superficial (225 µm;17.5 mJ/channel) and deep (1200 µm; 130.5 mJ/channel) channels, and PVP was delivered as a 3-minutes cycle of 1 minute pressure (+1.0 atm), 1 minute vacuum (-1.0 atm), and 1 minute pressure (+1.0 atm). Filling of laser channels was visualized with a colored biomarker liquid (n = 12 FCs, n = 588 channels). Nuclear magnetic resonance quantified intracutaneous deposition of topically applied polyethylene glycol (PEG400) over time (10 minutes, 1 hour, and 4 hours), investigated with (n = 36 FCs) and without (n = 30 FCs) PVP-filling. Two-dimensional mathematical simulation was used to simulate intradermal biodistribution and diffusion at a depth of 1,000 µm.RESULTS: Active filling with application of PVP increased the number of filled laser channels. At a depth of 1,000 µm, filling increased from 44% (AFXL) to 94% with one PVP cycle (AFXL + PVP; P < 0.01). Active filling greatly enhanced intracutaneous deposition of PEG400, resulting in a rapid delivery six-folding uptake at 10 minutes (AFXL 54 µg/ml vs. AFXL + PVP 303 µg/ml, P < 0.01). AFXL alone generated an inhomogeneous uptake of PEG400, which greatly improved with active filling, resulting in a uniform uptake within the entire tissue.CONCLUSION: Active filling with PVP secures filling of laser channels and induces a deeper, greater, more rapid delivery than conventional AFXL. This delivery technique has promise to improve treatment efficacy for medical treatments of dermally invasive lesions, such as BCCs.

KW - Administration, Cutaneous

KW - Animals

KW - Biomechanical Phenomena

KW - Diffusion

KW - Drug Delivery Systems

KW - Female

KW - Kinetics

KW - Lasers, Gas

KW - Polyethylene Glycols

KW - Pressure

KW - Skin

KW - Swine

KW - Vacuum

KW - Journal Article

U2 - 10.1002/lsm.22374

DO - 10.1002/lsm.22374

M3 - Journal article

C2 - 26280816

VL - 48

SP - 116

EP - 124

JO - Lasers in Surgery and Medicine

JF - Lasers in Surgery and Medicine

SN - 0196-8092

IS - 2

ER -

ID: 179877947